IMC-20D7S

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMC-20D7S, covering 2019-06-17 to 2019-06-17. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma [Phase 1]